Skip to main content
OpenTrials
Completed

NCT Number: NCT04572087

Ameliorating Cognitive Control in Binge Eating Disorder

There is evidence that impairment of impulse regulation is involved in the development and maintenance of eating disorders, especially in Binge Eating Disorder (BED). BED is characterized by recurrent episodes of binge eating with experienced loss of control over eating. Controlling impulsive behaviour, cognitive flexibility, planning and decision making are key abilities of impulse regulation. Some of these impaired cognitive functions are linked to decreased activity of certain brain regions. Transcranial direct current stimulation (tDCS) is a well-established method to alter brain activity. In the current project, we explore if a computer-assisted training programme for patients with BED that is combined with tDCS is feasible and able to ameliorate impulse regulation and impulsive eating behaviour. We hypothesize that the cognitive training programme with additional tDCS will result in a greater decrease of BED symptoms and a stronger increase in impulse regulation skills compared with the cognitive training programme without tDCS by using a placebo stimulation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Tübingen

Tübingen, 72076, Germany

About this study

Patients with BED form a subgroup of obese patients with a disinhibited eating pattern that is associated with major impairments in cognitive control. The dorsolateral prefrontal cortex (dlPFC) has been identified as a brain region closely tied to cognitive control processes and crucially involved in the control of eating behaviour. This suggests the dlPFC as a target for the modulation of cognitive control processes over eating in BED. This modulation can be achieved by both, a cognitive training task and by noninvasive brain stimulation using tDCS. In studies with healthy normal-weight participants, (1) different cognitive training task enhance control over eating behaviour, (2) tDCS is an effective tool to ameliorate cognitive control processes, and (3) has beneficial effects on motivational aspects of eating behaviour, i.e. food craving. Based on this evidence, we will use a combination of a cognitive control task and tDCS to enhance cognitive control over eating in patients with BED. This is to the best of our knowledge one of the first studies to use tDCS as an intervention to enhance cognitive control over eating in patients with BED.

o Sample size: We will allocate 40 patients in the trial, i.e. 20 patients in each study arm.

o Recruitment: Patients are recruited by announcements, mails to the distributor list of the university hospital, existing databases of patients, and current patients of the university hospital. Patients are screened by a standardized checklist. In- and exclusion criteria are checked during the screening procedure and during the baseline diagnostic before randomisation.

o Standard Operating Procedures: For the recruitment, diagnostic and experimental sessions, Standard Operating Procedures are documented for the experimenter. This includes the order of clinical interviews, questionnaires and operating with the technical measurement instruments. The experimenters are regularly supervised. All adverse events will be listed and severe adverse events will be reported immediately to the PIs.

o Quality assurance plan: Randomized allocation to the stimulation condition (verum vs. sahm) and statistical analyses is done externally by the Institute of Clinical Epidemiology and Applied Biometry, University Tübingen, Germany (ICEAB). Objective technical measurement instruments are mostly used to record data.

o Data checks: Data is recorded mostly by objective technical measurement instruments, so no external monitoring is needed. We will spot check entered questionnaire data, in particular binge eating frequency in the past four weeks will be double checked as this is the primary outcome (PO).

o Source data verification: Data are spot checked by comparing the entries in the source data with the entries in the database. Each PO entry will be double checked. There are pre-defined criteria for entering data into the database.

  • Data dictionary:

A data dictionary that contains detailed descriptions of each variable and how to be entered is available.

o Plan for missing data: Missing data and invalid data as well as the reasons will be recorded.

o Statistical analysis plan: A mixed model approach will be used to analyze the PO and secondary outcomes (SOs).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BED according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
  • Legal age
  • BMI above 20 kg/m2

Exclusion criteria

  • Insufficient knowledge of German language
  • Current pregnancy or lactation period
  • Current or lifetime psychotic disorder, bipolar-I disorder, current substance dependence, suicidality
  • Past bariatric surgery
  • Severe physical disease which influence weight or eating behaviour (e.g. severe diabetes) or neurologic disease
  • Non-removable metal parts in the area of the head
  • Pacemaker
  • Neuroleptics and benzodiazepine
  • impaired vision, ametropia, eye diseases

Treatment and study plan

Behavioral training and verum stimulation

Other

Cognitive control training and verum tDCS

Behavioral training and sham stimulation

Other

Cognitive control training and sham tDCS

Primary outcomes

  1. Binge eating frequency

    Time frame: assessed at baseline (T0) and at diagnostic post assessment four weeks after treatment (T8)

    Change of the frequency of Binge eating episodes in the last 4 weeks according to the Eating Disorder Examination Interview (EDE) between baseline (T0) and diagnostic post assessment (T8). The EDE is a validated semi-structured clinical interview.

Secondary outcomes

  1. Binge eating frequency follow-up

    Time frame: assessed at baseline (T0) and at 3 months follow-up (T9)

    Change of the frequency of Binge eating episodes in the last 4 weeks according to EDE between baseline (T0) and 3 months follow up (T9)

  2. antisaccade task

    Time frame: assessed at baseline (T0), the six training sessions within two weeks (T1-T6) and the post measurement of task performance within one week after the training (T7)

    antisaccade task error rate and latency assessed by eye tracking

  3. Go/No-Go task

    Time frame: at baseline (T0) and at the post measurement of task performance within one week after the training (T7)

    Go/No-Go task task error rate and latency

  4. stimulus rating

    Time frame: at baseline (T0) and and the post measurement of task performance within one week after the training (T7)

    one self-developed questionnaire including visual analogue scales (0-10 cm) concerning valence, appetite, wanting, liking of the presented stimuli

  5. Eating disorder pathology (EDE)

    Time frame: assessed at baseline (T0), at diagnostic post assessment four weeks after treatment (T8) and 3 months follow-up (T9)

    assessed by the Eating Disorder Examination (EDE), Range 0-6 with higer scores indication higer eating disorder pathology

  6. eating behaviour (TFEQ)

    Time frame: at baseline (T0), at the post measurement of task performance within one week after the training (T7) and at diagnostic post assessment four weeks after treatment (T8)

    assessed by the Three-factor Eating Questionnaire (TFEQ), Range 0-1 with higher scores indicating more pathological eating behaviour

  7. food craving (FCQ-S)

    Time frame: at baseline (T0), the six training sessions within two weeks (T1-T6) and the post measurement of task performance within one week after the training (T7)

    assessed by the Food Craving Questionnaire, State Version (FCQ-S), Range 1-5 with higher scores indicating higher food craving

  8. impulsive behaviours per week

    Time frame: at baseline (T0), the six training sessions within two weeks (T1-T6), the post measurement of task performance within one week after the training (T7) and at diagnostic post assessment four weeks after treatment (T8)

    assessed by a self-developed process analysis questionnaire, values > 0 (unlimited frequency) with higher scores indicating more impulsive behaviours per week

  9. impulsivity (UPPS)

    Time frame: at baseline (T0) and at diagnostic post assessment four weeks after treatment (T8)

    assessed by the "UPPS Impulsive Behavior Scale" (UPPS), Range 1-4 with higher scores indicating higher impulsivity

  10. well-being (WHO-5)

    Time frame: at baseline (T0), the post measurement of task performance within one week after the training (T7) and at diagnostic post assessment four weeks after treatment (T8)

    assessed by the "WHO (Five) - Well-being Questionnaire" (WHO-5), Range 0-5 with higher scores indicating higher well-being

  11. depressive symptoms (BDI II)

    Time frame: at baseline (T0) and at diagnostic post assessment four weeks after treatment (T8)

    assessed by the Becks Depression Inventory, Version 2 (BDI II), Range 0-3 with higher scores indicating higher depressive symptoms

  12. Body Mass Index (BMI)

    Time frame: at baseline (T0) and at diagnostic post assessment four weeks after treatment (T8)

    computed by objectively assessed weight and height

  13. acceptance and feasibility

    Time frame: from baseline (T0) throughout all measurement points until 3 months follow-up (T9)

    drop-out rate throughout T0 to T9, percentage of included patients from the eligible patients at T0

  14. evaluation of the training programme

    Time frame: assessed at the post measurement of task performance within one week after the training (T7)

    self-developed questionnaire at T7 (Range 1-5 with higher cores indicating more satisfaction with the training programme)

Sponsors and collaborators

Lead sponsor

Prof. Dr. Katrin Giel

Other

Registry information

Official study title

Ameliorating Cognitive Control in Binge Eating Disorder by Electrical Brain Stimulation

Acronym: ACCElect

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Oct 1, 2020
Registry last updated
May 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.